95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF
#302BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS
#303PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#304SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS
#305HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
#306ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME
#307FUSED BICYCLIC HETEROARYL AMIDE COMPOUND AS PROTEIN AGGREGATION INHIBITOR
#308NOVEL HETEROARYL COMPOUNDS
#309AT2R ANTAGONISTS AND USES THEREOF
#310COMPOUNDS
#311COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IMPAIRED ß-GALACTOSIDASE ACTIVITY
#312SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS
#313BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS
#314NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION
#315POLYSUBSTITUTED 4-HYDROXYPYRIDINE AND 4-HYDROXYQUINOLINE DERIVATIVES AS GPR84 ANTAGONISTS
#316DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#317DRUG DELIVERY SYSTEMS BASED ON ENDOPEROXIDES USEFUL IN DIAGNOSIS AND THERAPY, AND METHODS THEREOF
#318SOS1 INHIBITORS
#3191,3-BENZODIOXOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#320INDAZOLE COMPOUND AND PHARMACEUTICAL
#321Chemical Activators of Nicotinamide Mononucleotide adenylyltransferase 2 (NMNAT2) and Uses Thereof
#322PLPRO INHIBITORS
#323TLR MODULATOR AND USE THEREOF
#324ERBB/BTK INHIBITORS
#325INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES
#326NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF
#327COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS
#328DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS
#329Synthesis of MEK7 Inhibitors and methods of Use Thereof
#330DIAMINOBUTOXY-SUBSTITUTED ISOFLAVONOIDS AS MITOCHONDRIAL COMPLEX I INHIBITORS FOR CANCER TREATMENT
#331SOS1 Inhibitor With Pyrido-Fused Six-Membered Ring Structure
#332COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS
#333LPAR1 ANTAGONISTS AND USES THEREOF
#334PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#335Small molecule inhibitors of lanosterol synthase
#336QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF
#337QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF
#338SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS
#339COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K
#340COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#341SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATED CALCIUM CHANNELS AND USES THEREOF
#342PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF
#343AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
#344SMALL MOLECULE MODULATORS OF IL-17A, METHODS OF MAKING AND METHODS OF USING THEREOF
#3451H-BENZO[B]AZEPIN-2(3H)-ONE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER
#346RXFP1 AGONISTS
#347CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS
#348Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device
#349AMINOHETEROARYL KINASE INHIBITORS
#350ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#351ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#352PSMA Imaging Agents
#353NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE
#354SUBSTITUTED BENZOFURAN PROPYL AMINE MODULATORS OF MONOAMINERGIC TRANSPORTERS
#355NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#356PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY
#357FLUORINE-CONTAINING PYRAZOLE COMPOUND AND PRODUCTION METHOD THEREFOR
#358COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS
#359P2X4 RECEPTOR ANTAGONIST
#360PSMA Imaging Agents
#361ORGANIC COMPOUNDS
#362COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES
#363COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#364RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF
#365HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS
#366N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS AS MODULATORS OF SODIUM CHANNELS
#367Methods for treating cancer
#368AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
#369SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
#370C-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#371COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME
#372Substituted tetrahydrofurans as modulators of sodium channels
#373Substituted Quinoxalines
#374PHENOXY-ACETYL-THIOUREIDO-BENZENESULFONAMIDE DERIVATIVES, AND THEIR USES
#375FUNGICIDAL COMPOSITIONS
#376MULTI-TARGETED TYROSINE KINASE INHIBITORS EFFECTIVE IN ANTITUMOR USES
#377INHIBITORS OF TRANSGLUTAMINASES
#378MATERIALS FOR ELECTRONIC DEVICES
#379NOVEL INHIBITOR OF HYPE-MEDIATED AMPYLATION
#380PYRIMIDINEDIONE COMPOUNDS
#381BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS
#382ORGANIC LIGHT EMITTING DEVICE
#383IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE
#384INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS
#385NAMPT INHIBITORS AND USES THEREOF
#386SIGMA LIGAND COMPOUNDS AND USES THEREOF
#387PHENYL ACETAMIDE BASED IL-17A MODULATORS AND USES THEREOF
#388INHIBITORS OF TRANSGLUTAMINASES
#389NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS
#390PIKfyve Inhibitors
#391Cardiac sarcomere inhibitors
#392COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
#393CYCLIN K DEGRADER
#394CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE
#395NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF
#396BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
#397SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS
#398OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
#399SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
#400AMIDE COMPOUND AND USE THEREOF
#401ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#402HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT
#403MODULATORS OF A POTASSIUM CHANNEL AND OF TRPV1 CHANNEL AND USES THEREOF
#404ONIUM SALT, RESIST COMPOSITION, AND PATTERN FORMING PROCESS
#405Compounds for inhibiting NLRP3 and uses thereof
#406Compounds for inhibiting NLRP3 and uses thereof
#407COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#408SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
#409HETEROCYCLIC COMPOUNDS AS SEROTONIN (5-HT) 5-HT2A AND 5-HT2C RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#410Glucose Uptake Inhibitors
#411SULFONAMIDE OREXIN RECEPTOR AGONISTS AND USES THEREOF
#412COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
#413ARYL HYDROCARBON RECEPTOR MODULATORS AND THEIR USE IN THE TREATMENT OF DISEASES AND DISORDERS
#414MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS
#415UREA COMPOUND CONTAINING 2-HETEROAROMATIC RING SUBSTITUTION, PREPARATION METHOD THEREFOR AND USE THEREOF
#416INDOLINE COMPOUNDS FOR INHIBITING KIF18A
#417ORGANIC LIGHT EMITTING DEVICE
#418ORGANIC LIGHT EMITTING DEVICE
#419ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME
#420COMPOUNDS THAT INHIBIT PI3K ISOFORM ALPHA AND METHODS FOR TREATING CANCER
#421SOLID FORMS OF A DUAL RAF/MEK INHIBITOR
#422SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES
#423PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF
#424SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#425Heterocycle derivatives for treating TRPM3 mediated disorders
#426SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF
#427METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE
#428NOVEL CYCLOPROPYL COMPOUNDS
#429Modulators of mas-related g-protein receptor X2 and related products and methods
#430COMPOUND SERVING AS NLRP3 INHIBITOR
#431THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#432AROMATIC AMINE COMPOUNDS, AND COMPOSITIONS AND ORGANIC ELECTRONIC DEVICES INCLUDING THE SAME
#433HETEROARYL-THIO-SUBSTITUTED PYRONES
#434FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF
#435LACTONE AND LACTAM CONTAINING COMPOUNDS USEFUL AS IMMUNOMODULATORS
#436QUINOLINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS
#437TRIAZINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AND NEURODEGENERATIVE DISORDERS
#438AMIDE AND ETHER SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#439ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING SAME
#440Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
#4413,4-METHYLENEDIOXYMETHAMPHETAMINE AND RELATED PSYCHEDELICS AND USES THEREOF
#442INHIBITORS OF TRANSGLUTAMINASES
#443POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION
#444Novel Pyridine Compounds
#445HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#4461,3-SUBSTITUTED CYCLOBUTYL DERIVATIVES AND USES THEREOF
#447PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION
#4486-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES
#449BENZOMIDAZOL-1,2-YL AMDES AS Kv7 CHANNEL ACTIVATORS
#450FUSED PIPERIDINYL BICYCLIC AND RELATED COMPOUNDS AS MODULATORS OF C5A RECEPTOR
#451Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#452MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF
#4533-PYRROLYLSULFONAMIDE COMPOUNDS AS GPR17 ANTAGONISTS
#454BIARYL AMIDE AND HETEROARYL AMIDES FOR TREATMENT OF CANDIDA ALBICANS INFECTION
#455PYRANONE COMPOUNDS USEFUL TO MODULATE OMA1 PROTEASE
#456HYDROXY AND (HALO)ALKOXY SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
#457TRIAZOLE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS
#458PROCESS FOR PREPARING AN ERK INHIBITOR
#459SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER
#460Fused ring compound having urea structure
#461Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins
#462Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide
#463ORGANIC COMPOUND AND ORANIC LIGHT-EMITTING DIODE COMPRISING SAME BACKGROUND OF THE INVENTION
#464COMPOUNDS, DEVICES, AND USES THEREOF
#465HETEROAROMATIC ANALOGUES OF 3-BENZYLMENADIONE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION
#466ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#467Aryl-or heteroaryl-substituted benzene compounds
#468PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#469PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#470MAGL INHIBITORS
#471COMPOUNDS AND METHODS FOR TARGETING PATHOGENIC BLOOD VESSELS
#472HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#473COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS
#474PEPTIDE NUCLEIC ACIDS, SYNTHESIS, AND USES THEREOF
#475N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF
#476COMPOUNDS FOR TREATING CONDITIONS RELATED TO OXIDATIVE STRESS
#477QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#478USP30 INHIBITORS AND USES THEREOF
#479Organic Light-Emitting Compound And Organic Light-Emitting Device Comprising Same
#480SUBSTITUTED BENZAMIDES AS HERBICIDES
#481FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1
#482SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF
#483HERBICIDAL COMPOUNDS
#484COMPOUNDS WITH ARYLAMINE STRUCTURES
#485DEUBIQUITINASE-TARGETING CHIMERAS AND RELATED METHODS
#486GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE
#487ORGANIC COMPOUND, OPTICAL DEVICE, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE
#488HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND COMPOSITION FOR ORGANIC MATERIAL LAYER COMPRISING THE SAME
#489TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT
#490SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE
#491ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY
#492Delivery of therapeutic alkaloid compounds
#493EBNA1 Inhibitors and Methods Using Same
#494TEAD INHIBITORS
#495GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING GPX4-MEDIATED DISEASES
#496Aryl-OR heteroaryl-substituted benzene compounds
#497Aryl-or heteroaryl-substituted benzene compounds
#498Papain-like protease (PLpro) inhibitors
#499COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS
#500FXR REGULATOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
#501SUBSTITUTED TRIAZINE COMPOUND
#502BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5
#503Next Generation 5-HT2AR Agonists
#504PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#505SARS-COV-2 MPRO INHIBITOR COMPOUNDS
#506ORGANIC LIGHT EMITTING DEVICE
#507COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#508COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL AND OVARIAN CANCER
#509WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE
#510SUBSTITUTED QUINOLINE DERIVATIVES HAVING SOS1 INHIBITION ACTIVITIES AND USES THEREOF
#511ABIRATERONE DERIVATIVE, PREPARATION AND APPLICATION THEREOF
#512GLUTARIMIDES FOR MEDICAL TREATMENT
#513Inhibitors of RAD52 Recombination Protein and Methods Using Same
#514PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
#515Chromene derivatives as inhibitors of TCR-Nck interaction
#516SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS
#517SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY
#518Thyroid hormone receptor agonists and use thereof
#519INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION
#520SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#521BET PROTEIN INHIBITORS AND USE THEREOF
#522ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#523BROMODOMAIN INHIBITORS
#524ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE
#525N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
#526ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#527Theramutein modultors
#528OX2R Compounds
#529Pyrazolopyrimidine compounds as kinase Inhibitors
#530PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
#531COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#5328-(PICOLINAMIDE) SUBSTITUTED COUMARIN COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#533NOVEL INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#534Substituted piperidine compound and use thereof
#535MODULATORS OF THE INTEGRATED STRESS PATHWAY
#536ORGANIC ELECTRIC ELEMENT USING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF
#537CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME
#538AMINOHETEROARYL KINASE INHIBITORS
#539PHOSPHOINOSITIDE 3 KINASE BETA INHIBITORS AND COMPOSITIONS AND METHODS THEREOF
#540MULTI-TARGETED TYROSINE KINASE INHIBITORS AND THEIR PHARMACEUTICAL USES
#541SUBSTITUTED BENZENE COMPOUNDS
#542METHODS FOR INHIBITING FASCIN
#543RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF
#544Methods for treating cancer
#545COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#546BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
#547DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#548ESTER ANALOGS OF PSILOCIN, PROCESSES FOR THE PREPARATION THEREOF, AND METHODS OF USE
#549Catecholamine prodrugs for use in the treatment of Parkinson's disease
#550ACID ADDITION SALTS OF BENZIMIDAZOLE DERIVATIVE
#551PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS
#552Bicyclic carboxamides and methods of use thereof
#553COMPOSITIONS AND METHODS FOR INHIBITING IDO1
#554METHODS OF MODULATING ANDROGEN RECEPTOR CONDENSATES
#555Human plasma kallikrein inhibitors
#556Human plasma kallikrein inhibitors
#557Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof
#558SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES
#559CARBOXYLIC ACID, ACYL SULFONAMIDE AND ACYL SULFAMIDE-DERIVATIZED BICYCLIC AZA-HETEROAROMATICS AS SELECTIVE MCL-1 INHIBITORS AND AS DUAL MCL-1/BCL-2 INHIBITORS
#560METHOD FOR THE PREPARATION OF PYRAZOLE DERIVATIVES AS MODULATORS OF CFTR PROTEIN
#561PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS
#562HBV INHIBITOR AND ITS USE
#563HETEROCYCLIC CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF
#564INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
#565FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER
#566COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS
#567Compounds and methods for inhibiting fascin
#568TYK2 inhibitors and compositions and methods thereof
#569ATF6 INHIBITORS AND USES THEREOF
#570COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS
#571INHIBITORS OF TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) AND USES THEREOF
#572FUSED HETEROCYCLIC MESCALINE DERIVATIVES
#573MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
#574PROTEASOME ACTIVITY ENHANCING COMPOUNDS
#575KIT KINASE INHIBITORS AND METHODS OF USE THEREOF
#576RATIONAL DESIGN, OPTIMIZATION, AND BIOLOGICAL EVALUATION OF NOVEL MEK4 INHIBITORS AGAINST PANCREATIC ADENOCARCINOMA
#577PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING
#578Antagonists of T2R54 and compositions and uses thereof
#5792,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT
#580Nitrogen-containing compound, and electronic element and electronic device comprising same
#5814-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3
#582DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT
#583HETEROCYCLIC COMPOUNDS AS PESTICIDES
#584ACRYLAMIDE COMPOUNDS
#585TARGETED DELIVERY OF 1,2,4,5 TETRAOXANE COMPOUNDS AND THEIR USES
#586Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins
#587PROTEIN-PROTEIN INTERACTION MODULATORS OF AURORA KINASE A AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER
#588MCT4 inhibitors for treating disease
#589HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#590Heterocycle RMB39 Modulators
#591MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#592MATERIALS FOR ELECTRONIC DEVICES
#593NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND
#594COMPOSITIONS AND METHODS FOR INHIBITING M PRO PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-COV-2 INFECTION
#595CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY
#596DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#597PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#5982-Methyl-Quinazolines
#599TEAD INHIBITORS AND USES THEREOF
#600ORGANIC LIGHT EMITTING DEVICE